Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.72 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.60 |
| ▸ | PTPRC | P08575 | 1/20 | 0.60 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.60 |
| ▸ | PTPRB | P23467 | 1/20 | 0.60 |
| ▸ | PTPRE | P23469 | 1/20 | 0.60 |
| ▸ | RAB7A | P51149 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
| ▸ | CFTR | P13569 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | FABP4 | P15090 | 3/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4079863 | 0.85 | CNR2 (0.72) | CNR2CNR1HTTKMT2AGAA | |
| SCHEMBL4080262 | 0.84 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL5453432 | 0.81 | PTPN1 (0.71) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL3760411 | 0.78 | PTPN1 (0.67) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL4090461 | 0.76 | CNR2 (0.70) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL4095514 | 0.76 | CNR2 (0.73) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL4312414 | 0.76 | PTPN1 (1.00) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL5741314 | 0.76 | PTPN1 (0.75) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL4084848 | 0.75 | RAB7A (0.56) | CNR2PTPN1PTPRCPTPN2PTPRB | |
| SCHEMBL5449718 | 0.75 | FLT3 (0.66) | CNR2L3MBTL1MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8338623-B2 | N-{3-[(2,5-dimethylmorpholin-4-yl)carbonyl]-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl}hexahydro-2,5-methanopentalene-3a(1H)-carboxamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants | ABBVIE INC. (US) | 2012-12-25 | — | — | US | disclosed |
| US-20090018114-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | ABBOTT LABORATORIES (US) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018114-A1 | NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS | CNR1, CNR2, GPR18 | CNR2 2/4885PTPN1 2348/4885PTPRC 1716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.